Exact Mass: 409.14937519999995

Exact Mass Matches: 409.14937519999995

Found 89 metabolites which its exact mass value is equals to given mass value 409.14937519999995, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

linustatin

2-methyl-2-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]propanenitrile

C16H27NO11 (409.15840319999995)


   
   

IWR-1-endo

4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-benzamide

C25H19N3O3 (409.1426344)


   

Ezetimibe

(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)


Ezetimibe is an anti-hyperlipidemic medication which is used to lower cholesterol levels. Specifically, it appears to bind to a critical mediator of cholesterol absorption, the Niemann-Pick C1-Like 1 (NPC1L1) protein on the gastrointestinal tract epithelial cells as well as in hepatocytes. D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D009676 - Noxae > D000963 - Antimetabolites Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.

   

Chondroitin D-glucuronate

(2S,3S,4S,5R,6R)-4,5-dihydroxy-6-{[(2R,3R,4R,5R,6R)-3-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy}-3-methyloxane-2-carboxylic acid

C16H27NO11 (409.15840319999995)


This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.

   

dermatan L-iduronate

(2R,3S,4S,5R,6R)-4,5-dihydroxy-6-{[(2R,3R,4R,5R,6R)-3-hydroxy-5-[(1-hydroxyethylidene)amino]-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy}-3-methyloxane-2-carboxylic acid

C16H27NO11 (409.15840319999995)


This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.

   

Acetylcorynoline

13,24-Dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl acetic acid

C23H23NO6 (409.1525298)


   

N-((6-Methyl-5-oxo-3-thiomorpholinyl)carbonyl)-L-histidyl-L-proline

1-(2-{[hydroxy(5-hydroxy-6-methyl-3,6-dihydro-2H-1,4-thiazin-3-yl)methylidene]amino}-3-(1H-imidazol-5-yl)propanoyl)pyrrolidine-2-carboxylate

C17H23N5O5S (409.14198280000005)


   

Piclozotan

3-chloro-4-(4-{1,2,3,6-tetrahydro-[2,4-bipyridine]-1-yl}butyl)-4,5-dihydro-1,4-benzoxazepin-5-one

C23H24ClN3O2 (409.1556954)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist

   

(3R,4S)-1-(4-Fluorophenyl)-4-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-3-(4-hydroxyphenyl)azetidin-2-one

(3R,4S)-1-(4-Fluorophenyl)-4-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-3-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)


   

Linustatin

2-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-methylpropanenitrile

C16H27NO11 (409.15840319999995)


Linustatin is a member of the class of compounds known as cyanogenic glycosides. Cyanogenic glycosides are glycosides in which the aglycone moiety contains a cyanide group. Linustatin is soluble (in water) and a very weakly acidic compound (based on its pKa). Linustatin can be found in a number of food items such as broad bean, plains prickly pear, shea tree, and longan, which makes linustatin a potential biomarker for the consumption of these food products.

   

Acetylcorynoline

[(1R,12S,13R)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl] acetate

C23H23NO6 (409.1525298)


Acetylcorynoline is a benzophenanthridine alkaloid. Acetylcorynoline is a natural product found in Corydalis bungeana, Corydalis remota, and other organisms with data available. Acetylcorynoline is the major alkaloid component derived from Corydalis bungeana, and has anti-inflammatory properties[1]. Acetylcorynoline is the major alkaloid component derived from Corydalis bungeana, and has anti-inflammatory properties[1].

   

5-O-Demethylpaxanthonin

5-O-Demethylpaxanthonin

C23H23NO6 (409.1525298)


   

N1-(2-Cyanoethyl)-N1-cyclohexyl-3-nitro-4-(phenylthio)benzamide

N1-(2-Cyanoethyl)-N1-cyclohexyl-3-nitro-4-(phenylthio)benzamide

C22H23N3O3S (409.1460048)


   

FucGlcNAcGA

FucGlcNAcGA

C16H27NO11 (409.15840319999995)


[Chemical] Source; sea squirt H-antigen (limited periodate oxide)

   

Fluoxetine Succinamic Acid

Fluoxetine Succinamic Acid

C21H22F3NO4 (409.15008480000006)


CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 702

   
   
   
   

(-)-ethyl (reframidin-15-yl)acetate

(-)-ethyl (reframidin-15-yl)acetate

C23H23NO6 (409.1525298)


   
   
   
   
   
   
   
   

Ezetimibe

Ezetimibe

C24H21F2NO3 (409.14894200000003)


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D009676 - Noxae > D000963 - Antimetabolites Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.

   

Cys Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

C14H27N5O5S2 (409.1453532)


   

Cys Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

C14H27N5O5S2 (409.1453532)


   

Cys Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

C14H27N5O5S2 (409.1453532)


   

Cys Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)


   

Cys Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

C14H27N5O5S2 (409.1453532)


   

Cys Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)


   

Gly Cys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C14H27N5O5S2 (409.1453532)


   

Gly Cys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)


   

Gly Lys Cys Cys

(2R)-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)


   

Lys Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C14H27N5O5S2 (409.1453532)


   

Lys Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)


   

Lys Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C14H27N5O5S2 (409.1453532)


   

IWR-1-exo

4-[(3aR,4S,7R,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinyl-benzamide

C25H19N3O3 (409.1426344)


   
   
   
   
   
   

1H-Pyrrolo[2,3-b]pyridine-3-methanamine, 4-bromo-N,N-dimethyl-1-[tris(1-methylethyl)silyl]-

1H-Pyrrolo[2,3-b]pyridine-3-methanamine, 4-bromo-N,N-dimethyl-1-[tris(1-methylethyl)silyl]-

C19H32BrN3Si (409.1548732)


   

2-(TRIBUTYLSTANNYL)BENZOXAZOLE

2-(TRIBUTYLSTANNYL)BENZOXAZOLE

C19H31NOSn (409.1427506)


   

[2-(diethylcarbamoyl)-4-(2,4-difluorophenyl)phenyl] benzoate

[2-(diethylcarbamoyl)-4-(2,4-difluorophenyl)phenyl] benzoate

C24H21F2NO3 (409.14894200000003)


   

Reboxetine mesylate

Reboxetine (mesylate)

C20H27NO6S (409.1559002000001)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators Reboxetine mesylate (FCE20124 mesylate) is a potent, selective, and specific noradrenaline reuptake inhibitor (NARI) for the research of depression. Reboxetine mesylate inhibits the uptake of norepinephrine, with a Ki of 8 nM[1].

   
   

ent-Ezetimibe

ent-Ezetimibe

C24H21F2NO3 (409.14894200000003)


ent-Ezetimibe (ent-SCH 58235) is the RRS-enantiomer of Ezetimibe. Ezetimibe is a potent cholesterol absorption inhibitor.?Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent?Nrf2 activator[1].

   
   

9,9-(2,6-pyridinediyl)bis-9H-carbazole

9,9-(2,6-pyridinediyl)bis-9H-carbazole

C29H19N3 (409.15788940000004)


   

2(1H)-Isoquinolinecarboxylic acid, 8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-, 1,1-dimethylethyl ester

2(1H)-Isoquinolinecarboxylic acid, 8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-, 1,1-dimethylethyl ester

C22H23N3O3S (409.1460048)


   

Cerlapirdine

Cerlapirdine

C22H23N3O3S (409.1460048)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Cerlapirdine (SAM-531, PF-05212365) is a selective and potent full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine has the potential for researching the Alzheimer's disease[1].

   

trans-1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one

trans-1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)


   

1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one

1-(4-Fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)


   

4,5-Dimethyl-2-[[1-oxo-2-[4-(phenylmethyl)-1-pyridin-1-iumyl]ethyl]amino]-3-thiophenecarboxylic acid ethyl ester

4,5-Dimethyl-2-[[1-oxo-2-[4-(phenylmethyl)-1-pyridin-1-iumyl]ethyl]amino]-3-thiophenecarboxylic acid ethyl ester

C23H25N2O3S+ (409.15858000000003)


   

N-[4-({[5-(Dimethylamino)-1-Naphthyl]sulfonyl}amino)butyl]-3-Sulfanylpropanamide

N-[4-({[5-(Dimethylamino)-1-Naphthyl]sulfonyl}amino)butyl]-3-Sulfanylpropanamide

C19H27N3O3S2 (409.14937519999995)


   

3-[3-[[(2S)-2,3-dihydroxypropyl]amino]phenyl]-4-(5-fluoro-1-methylindol-3-yl)pyrrole-2,5-dione

3-[3-[[(2S)-2,3-dihydroxypropyl]amino]phenyl]-4-(5-fluoro-1-methylindol-3-yl)pyrrole-2,5-dione

C22H20FN3O4 (409.14377720000005)


   

(3R,4S)-1-(4-Fluorophenyl)-4-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-3-(4-hydroxyphenyl)azetidin-2-one

(3R,4S)-1-(4-Fluorophenyl)-4-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-3-(4-hydroxyphenyl)azetidin-2-one

C24H21F2NO3 (409.14894200000003)


   
   
   
   
   
   
   

2,4-Dibenzyl-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,4H)-trione

2,4-Dibenzyl-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,4H)-trione

C25H19N3O3 (409.1426344)


   
   

SN-38 carboxylate

SN-38 carboxylate

C22H21N2O6 (409.1399546)


A hydroxy monocarboxylic acid anion that is the conjugate base of SN-38 carboxylic acid, obtained from the deprotonation of the carboxy group. It is the major microspecies at pH 7.3.

   
   
   

FT113

FT113

C22H20FN3O4 (409.14377720000005)


FT113 is a potent and orally active fatty acid synthase (FASN) inhibitor, with an IC50 of 213 nM for full-length recombinant human FASN enzyme. In cell-based assay, FT113 blocks FASN activity in BT474 cells (IC50, 90 nM). FT113 shows anti-proliferative activity, and exhibits anti-cancer activity both in vitro and in vivo[1].

   

7-acetyl-1,8-dihydroxy-3-methoxy-5-methyl-4-(3-methylbut-2-en-1-yl)cyclohepta[b]quinoline-6,11-dione

7-acetyl-1,8-dihydroxy-3-methoxy-5-methyl-4-(3-methylbut-2-en-1-yl)cyclohepta[b]quinoline-6,11-dione

C23H23NO6 (409.1525298)


   

11-hydroxy-7-(1-hydroxyethylidene)-3-methoxy-5-methyl-4-(3-methylbut-2-en-1-yl)cyclohepta[b]quinoline-1,6,8-trione

11-hydroxy-7-(1-hydroxyethylidene)-3-methoxy-5-methyl-4-(3-methylbut-2-en-1-yl)cyclohepta[b]quinoline-1,6,8-trione

C23H23NO6 (409.1525298)


   

acetycorynoline

NA

C23H23NO6 (409.1525298)


{"Ingredient_id": "HBIN014438","Ingredient_name": "acetycorynoline","Alias": "NA","Ingredient_formula": "C23H23NO6","Ingredient_Smile": "CC(=O)OC1CC2=CC3=C(C=C2C4C1(C5=C(CN4C)C6=C(C=C5)OCO6)C)OCO3","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37010","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

acetylisocorynoline

NA

C23H23NO6 (409.1525298)


{"Ingredient_id": "HBIN014479","Ingredient_name": "acetylisocorynoline","Alias": "NA","Ingredient_formula": "C23H23NO6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "438","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

ethyl 2-{23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-22-yl}acetate

ethyl 2-{23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-22-yl}acetate

C23H23NO6 (409.1525298)


   

13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl acetate

13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl acetate

C23H23NO6 (409.1525298)


   

(1s,12r,13s)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl acetate

(1s,12r,13s)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl acetate

C23H23NO6 (409.1525298)


   

2-[(1s,4s)-2,2-dimethyl-4-(prop-1-en-2-yl)cyclopentyl]-1,3,5-trihydroxy-6-nitrosoxanthen-9-one

2-[(1s,4s)-2,2-dimethyl-4-(prop-1-en-2-yl)cyclopentyl]-1,3,5-trihydroxy-6-nitrosoxanthen-9-one

C23H23NO6 (409.1525298)


   

(1s,13s)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl acetate

(1s,13s)-13,24-dimethyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-2,4(8),9,14(22),15,17(21)-hexaen-12-yl acetate

C23H23NO6 (409.1525298)


   

ethyl 2-[(1r,12s,22s)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-22-yl]acetate

ethyl 2-[(1r,12s,22s)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaen-22-yl]acetate

C23H23NO6 (409.1525298)